Wang Xiaodong — SEC insider filings

SEC reporting owner CIK 1662982. 45 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 45 filings on record, filed 2020-08-12 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BeOne Medicines Ltd. (ONC)Director45—207 legs · 622,131 sh · $159,151,89356

Insider filings — Wang Xiaodong

FiledFormIssuerReported transactionsSource
2026-11-124BeOne Medicines Ltd. (ONC)Gift (G): 1,183 @ $0EDGAR
2026-10-294BeOne Medicines Ltd. (ONC)Option exercise (M): 31,028 @ $36.90 · Sale (S): 880 @ $355.56 · Sale (S): 1,440 @ $355.62 · Sale (S): 1,239 @ $357.54 · Sale (S): 1,681 @ $358.75 · Sale (S): 1,280 @ $359.72 · +7 moreEDGAR
2026-10-154BeOne Medicines Ltd. (ONC)Option exercise (M): 31,027 @ $36.90 · Sale (S): 7,167 @ $349.56 · Sale (S): 10,361 @ $350.47 · Sale (S): 5,681 @ $351.40 · Sale (S): 6,558 @ $352.57 · Sale (S): 1,260 @ $353.24 · +1 moreEDGAR
2026-09-304BeOne Medicines Ltd. (ONC)Option exercise (M): 31,028 @ $36.90 · Sale (S): 160 @ $356.97 · Sale (S): 120 @ $358.71 · Sale (S): 40 @ $359.16 · Sale (S): 2,241 @ $361.05 · Sale (S): 4,239 @ $362.17 · +6 moreEDGAR
2026-09-104BeOne Medicines Ltd. (ONC)Sale (S): 1,181 @ $345.38 · Sale (S): 2,841 @ $346.16 · Sale (S): 1,517 @ $347.39 · Sale (S): 1,721 @ $348.01 · Option exercise (M): 31,027 @ $36.90 · Sale (S): 7,492 @ $348.31 · +4 moreEDGAR
2026-06-154BeOne Medicines Ltd. (ONC)Grant/award (A): 99,892 @ $0 · Grant/award (A): 193,492 (derivative) @ $0EDGAR
2025-11-124BeOne Medicines Ltd. (ONC)Gift (G): 424,073 @ $0EDGAR
2025-09-114BeOne Medicines Ltd. (ONC)Gift (G): 148,096 @ $0EDGAR
2025-06-254BeOne Medicines Ltd. (ONC)Sale (S): 300 @ $263.50 · Sale (S): 1,100 @ $265.35 · Sale (S): 507 @ $266.57 · Sale (S): 100 @ $267.81EDGAR
2025-06-124BeOne Medicines Ltd. (ONC)Grant/award (A): 98,696 @ $0 · Option exercise (M): 41,760 @ $6.50 · Sale (S): 2,901 @ $261.20 · Sale (S): 15,878 @ $262.20 · Sale (S): 16,094 @ $263.17 · Sale (S): 6,787 @ $264.08 · +3 moreEDGAR
2025-05-154BeiGene, Ltd. (BGNE)Option exercise (M): 41,760 @ $6.50 · Sale (S): 10,221 @ $222.83 · Sale (S): 21,235 @ $223.41 · Sale (S): 10,104 @ $224.32 · Sale (S): 200 @ $225.68 · Option exercise (M): 542,880 (derivative) @ $0EDGAR
2025-04-164BeiGene, Ltd. (BGNE)Option exercise (M): 41,760 @ $6.50 · Sale (S): 995 @ $237.56 · Sale (S): 805 @ $238.48 · Sale (S): 2,884 @ $239.51 · Sale (S): 5,516 @ $240.41 · Sale (S): 2,229 @ $241.51 · +9 moreEDGAR
2025-03-204BeiGene, Ltd. (BGNE)Option exercise (M): 41,760 @ $6.50 · Sale (S): 2,417 @ $258.25 · Sale (S): 6,926 @ $259.08 · Sale (S): 2,694 @ $259.86 · Sale (S): 10,448 @ $261.44 · Sale (S): 11,245 @ $262.12 · +3 moreEDGAR
2025-03-134BeiGene, Ltd. (BGNE)Gift (G): 158,717 @ $0EDGAR
2025-03-064BeiGene, Ltd. (BGNE)Sale (S): 700 @ $251.70 · Sale (S): 2,000 @ $252.72 · Sale (S): 825 @ $253.55 · Sale (S): 1,275 @ $254.77 · Sale (S): 1,214 @ $255.71 · Sale (S): 1,809 @ $256.83 · +1 moreEDGAR
2025-02-064BeiGene, Ltd. (BGNE)Option exercise (M): 41,760 @ $6.50 · Sale (S): 9,099 @ $223.00 · Sale (S): 1,519 @ $224.18 · Sale (S): 2,161 @ $225.27 · Sale (S): 17,805 @ $226.35 · Sale (S): 9,776 @ $227.00 · +2 moreEDGAR
2025-01-084BeiGene, Ltd. (BGNE)Option exercise (M): 41,760 @ $6.50 · Sale (S): 19,251 @ $175.46 · Sale (S): 11,310 @ $176.67 · Sale (S): 4,260 @ $177.42 · Sale (S): 5,638 @ $178.39 · Sale (S): 1,301 @ $179.18 · +1 moreEDGAR
2024-12-124BeiGene, Ltd. (BGNE)Option exercise (M): 41,760 @ $6.50 · Sale (S): 2,600 @ $183.60 · Sale (S): 7,063 @ $184.83 · Sale (S): 9,956 @ $185.73 · Sale (S): 9,266 @ $186.99 · Sale (S): 6,350 @ $187.60 · +7 moreEDGAR
2024-11-294BeiGene, Ltd. (BGNE)Option exercise (M): 38,461 @ $6.50 · Sale (S): 4,425 @ $187.16 · Sale (S): 300 @ $187.61 · Sale (S): 5,875 @ $187.98 · Sale (S): 400 @ $188.55 · Sale (S): 2,700 @ $189.17 · +13 moreEDGAR
2024-08-144BeiGene, Ltd. (BGNE)Gift (G): 301,457 @ $0EDGAR
2024-06-074BeiGene, Ltd. (BGNE)Grant/award (A): 108,992 @ $0 · Grant/award (A): 410,657 (derivative) @ $0EDGAR
2023-12-044BeiGene, Ltd. (BGNE)Gift (G): 71,890 @ $0 · Other (J): 172,372 @ $0EDGAR
2023-06-204BeiGene, Ltd. (BGNE)Grant/award (A): 86,216 @ $0 · Grant/award (A): 327,249 (derivative) @ $0EDGAR
2023-03-204BeiGene, Ltd. (BGNE)Gift (G): 67,444 @ $0EDGAR
2023-03-104BeiGene, Ltd. (BGNE)Option exercise (M): 67,635 @ $0.13 · Sale (S): 3,433 @ $223.00 · Sale (S): 7,458 @ $224.01 · Sale (S): 12,534 @ $224.92 · Sale (S): 400 @ $225.35 · Sale (S): 200 @ $226.61 · +4 moreEDGAR
2023-01-174BeiGene, Ltd. (BGNE)Sale (S): 4,099 @ $260.31 · Sale (S): 901 @ $261.48EDGAR
2023-01-114BeiGene, Ltd. (BGNE)Sale (S): 900 @ $250 · Sale (S): 1,600 @ $250.09 · Sale (S): 200 @ $250.39 · Sale (S): 1,250 @ $252.22 · Sale (S): 950 @ $253.57 · Sale (S): 100 @ $254EDGAR
2022-12-154BeiGene, Ltd. (BGNE)Sale (S): 1,392 @ $210.59 · Sale (S): 956 @ $211.66 · Sale (S): 665 @ $212.38EDGAR
2022-11-304BeiGene, Ltd. (BGNE)Gift (G): 52,000 @ $0EDGAR
2022-11-174BeiGene, Ltd. (BGNE)Sale (S): 1,987 @ $210.14EDGAR
2022-09-084BeiGene, Ltd. (BGNE)Gift (G): 33,410 @ $0EDGAR
2022-08-094BeiGene, Ltd. (BGNE)Sale (S): 300 @ $186.69 · Sale (S): 200 @ $188.87 · Sale (S): 100 @ $190.19 · Sale (S): 100 @ $191.60 · Sale (S): 2,100 @ $193.70 · Sale (S): 600 @ $194.38 · +19 moreEDGAR
2022-06-244BeiGene, Ltd. (BGNE)Grant/award (A): 83,499 @ $0 · Grant/award (A): 471,913 (derivative) @ $0EDGAR
2021-11-104BeiGene, Ltd. (BGNE)Sale (S): 300 @ $342.71 · Sale (S): 200 @ $343.84 · Sale (S): 300 @ $344.96 · Sale (S): 775 @ $346.83 · Sale (S): 440 @ $348.03 · Sale (S): 662 @ $348.89 · +7 moreEDGAR
2021-11-104BeiGene, Ltd. (BGNE)Sale (S): 400 @ $343.10 · Sale (S): 100 @ $343.84 · Sale (S): 300 @ $344.96 · Sale (S): 700 @ $346.81 · Sale (S): 402 @ $347.71 · Sale (S): 700 @ $348.82 · +8 moreEDGAR
2021-07-014BeiGene, Ltd. (BGNE)Sale (S): 300 @ $342.68 · Sale (S): 437 @ $345.88 · Sale (S): 1,100 @ $347.31 · Sale (S): 1,500 @ $348.64 · Sale (S): 1,211 @ $349.89 · Sale (S): 300 @ $350.59EDGAR
2021-06-214BeiGene, Ltd. (BGNE)Grant/award (A): 39,000 @ $0 · Grant/award (A): 241,839 (derivative) @ $0EDGAR
2021-05-124BeiGene, Ltd. (BGNE)Option exercise (M): 44,109 @ $0.13 · Option exercise (M): 3,394 @ $0.13 · Sale (S): 1,100 @ $299.40 · Sale (S): 1,594 @ $300.20 · Sale (S): 311 @ $302.21 · Sale (S): 389 @ $303.10 · +1 moreEDGAR
2020-12-174BeiGene, Ltd. (BGNE)Gift (G): 165,295 @ $0EDGAR
2020-12-144BeiGene, Ltd. (BGNE)Gift (G): 88,010 @ $0 · Gift (G): 1,244,542 @ $0 · Gift (G): 1,244,542 @ $0EDGAR
2020-10-204BeiGene, Ltd. (BGNE)Sale (S): 5,000 @ $320EDGAR
2020-10-074BeiGene, Ltd. (BGNE)Sale (S): 5,000 @ $300EDGAR
2020-09-294BeiGene, Ltd. (BGNE)Sale (S): 4,380 @ $280.29 · Sale (S): 620 @ $281.34EDGAR
2020-09-214BeiGene, Ltd. (BGNE)Sale (S): 4,916 @ $260.26 · Sale (S): 84 @ $261.12EDGAR
2020-08-124BeiGene, Ltd. (BGNE)Gift (G): 1,560 @ $0 · Sale (S): 1,500 @ $208.91 · Sale (S): 1,194 @ $209.91 · Sale (S): 100 @ $210.59 · Sale (S): 400 @ $213.15 · Sale (S): 400 @ $214.83 · +1 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1662982 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs